Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
- Conditions
- Meningitis, CryptococcalHIV Infections
- Registration Number
- NCT00002074
- Lead Sponsor
- Pfizer
- Brief Summary
To compare the safety and effectiveness of fluconazole and amphotericin B as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (39)
Univ of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
Tucson Veterans Administration Med Ctr
🇺🇸Tucson, Arizona, United States
Dr Richard Meyer
🇺🇸Los Angeles, California, United States
Davies Med Ctr
🇺🇸San Francisco, California, United States
Dr Paul Rothman
🇺🇸Sherman Oaks, California, United States
Wilmington Hosp / Med Ctr of Delaware
🇺🇸Wilmington, Delaware, United States
George Washington Univ Med Ctr
🇺🇸Washington, District of Columbia, United States
Univ of Florida College of Medicine
🇺🇸Gainesville, Florida, United States
Univ of South Florida
🇺🇸Tampa, Florida, United States
Emory Univ School of Medicine
🇺🇸Atlanta, Georgia, United States
Scroll for more (29 remaining)Univ of Alabama at Birmingham🇺🇸Birmingham, Alabama, United States